Non-Hodgkin lymphoma, refractory

Clinical trials for Non-Hodgkin lymphoma, refractory explained in plain language.

Never miss a new study

Get alerted when new Non-Hodgkin lymphoma, refractory trials appear

Sign up with your email to follow new studies for Non-Hodgkin lymphoma, refractory, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Patient's own t cells engineered to hunt lymphoma in early trial

Cure Recruiting now

Researchers are testing a personalized cell therapy called MT-601 in adults with Hodgkin or non-Hodgkin lymphoma that has come back or stopped responding to treatment. MT-601 is made from each participant's own T cells, which are trained in the lab to recognize several targets fo…

Matched conditions: NON-HODGKIN LYMPHOMA, REFRACTORY

Phase 1 • Sponsor: Marker Therapeutics, Inc. • Aim: Cure

Last updated Sep 17, 2026 00:00 UTC

Non-Hodgkin lymphoma, refractory

Get alerted when new Non-Hodgkin lymphoma, refractory trials appear

Patient's own t cells engineered to hunt lymphoma in early trial